

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.98574620 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.21458017 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.21458017 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.73980930 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.69104365 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.69104365 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.69104365 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.69104365 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.69104365 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.69104365 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.29121215 |
| 12 | negative T cell selection (GO:0043383) | 5.27919641 |
| 13 | negative thymic T cell selection (GO:0045060) | 5.13952363 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.04999651 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.96495517 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.96495517 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.83397919 |
| 18 | leukocyte aggregation (GO:0070486) | 4.81734801 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.78832755 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.71462228 |
| 21 | response to interleukin-15 (GO:0070672) | 4.70924981 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67591209 |
| 23 | detection of other organism (GO:0098543) | 4.64936745 |
| 24 | positive T cell selection (GO:0043368) | 4.63230598 |
| 25 | B cell receptor signaling pathway (GO:0050853) | 4.61457611 |
| 26 | interferon-gamma production (GO:0032609) | 4.60696264 |
| 27 | positive thymic T cell selection (GO:0045059) | 4.53570301 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 4.51725208 |
| 29 | microglial cell activation (GO:0001774) | 4.40817057 |
| 30 | neutrophil activation involved in immune response (GO:0002283) | 4.38431355 |
| 31 | T cell migration (GO:0072678) | 4.36722949 |
| 32 | T cell selection (GO:0045058) | 4.36721020 |
| 33 | regulation of B cell differentiation (GO:0045577) | 4.34853456 |
| 34 | detection of bacterium (GO:0016045) | 4.31264585 |
| 35 | ribosomal small subunit assembly (GO:0000028) | 4.28177928 |
| 36 | detection of external biotic stimulus (GO:0098581) | 4.23196063 |
| 37 | thymic T cell selection (GO:0045061) | 4.22813543 |
| 38 | mature B cell differentiation (GO:0002335) | 4.21601960 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15317375 |
| 40 | mast cell activation (GO:0045576) | 4.14838194 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 4.11892867 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.11353137 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.07642379 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.99961141 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.97956953 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.92217244 |
| 47 | response to host immune response (GO:0052572) | 3.92217244 |
| 48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.91471177 |
| 49 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.83839513 |
| 50 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.82307634 |
| 51 | respiratory burst (GO:0045730) | 3.81798803 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.80601125 |
| 53 | mast cell activation involved in immune response (GO:0002279) | 3.79927882 |
| 54 | mast cell degranulation (GO:0043303) | 3.79927882 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.77642400 |
| 56 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.74533415 |
| 57 | response to peptidoglycan (GO:0032494) | 3.72786765 |
| 58 | neutrophil mediated immunity (GO:0002446) | 3.72624891 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71261662 |
| 60 | mature B cell differentiation involved in immune response (GO:0002313) | 3.68709920 |
| 61 | macrophage activation (GO:0042116) | 3.67249157 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.67177461 |
| 63 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.66556786 |
| 64 | T cell homeostasis (GO:0043029) | 3.65456694 |
| 65 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.61610313 |
| 66 | response to host (GO:0075136) | 3.61610313 |
| 67 | response to host defenses (GO:0052200) | 3.61610313 |
| 68 | T cell receptor signaling pathway (GO:0050852) | 3.60761791 |
| 69 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.60737456 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.55630406 |
| 71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.50950782 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.47105227 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.46837180 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44292081 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.42021550 |
| 76 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.41662995 |
| 77 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.40929614 |
| 78 | granulocyte activation (GO:0036230) | 3.37427608 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.35158362 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.35158362 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 3.34461187 |
| 82 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34418305 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.32702008 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30738688 |
| 85 | dendritic cell migration (GO:0036336) | 3.27239802 |
| 86 | T cell costimulation (GO:0031295) | 3.22018418 |
| 87 | viral transcription (GO:0019083) | 3.21986420 |
| 88 | definitive hemopoiesis (GO:0060216) | 3.21910737 |
| 89 | lymphocyte homeostasis (GO:0002260) | 3.20016612 |
| 90 | lymphocyte costimulation (GO:0031294) | 3.18613165 |
| 91 | myeloid dendritic cell activation (GO:0001773) | 3.18371055 |
| 92 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.17653427 |
| 93 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.17653427 |
| 94 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16615868 |
| 95 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.14391355 |
| 96 | negative regulation of adaptive immune response (GO:0002820) | 3.14266846 |
| 97 | positive regulation of mast cell activation (GO:0033005) | 3.14034988 |
| 98 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.13171223 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 3.10626142 |
| 100 | megakaryocyte development (GO:0035855) | 3.09503062 |
| 101 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.09125516 |
| 102 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09097051 |
| 103 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.08263176 |
| 104 | regulation of mast cell degranulation (GO:0043304) | 3.08058366 |
| 105 | activated T cell proliferation (GO:0050798) | 3.07527037 |
| 106 | T cell differentiation (GO:0030217) | 3.07259995 |
| 107 | positive regulation of granulocyte differentiation (GO:0030854) | 3.06439306 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 3.05969841 |
| 109 | negative regulation of B cell mediated immunity (GO:0002713) | 3.03994714 |
| 110 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.03994714 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 3.03128174 |
| 112 | alpha-beta T cell activation (GO:0046631) | 3.01946347 |
| 113 | cellular response to zinc ion (GO:0071294) | 3.01042854 |
| 114 | lymphoid progenitor cell differentiation (GO:0002320) | 2.98782596 |
| 115 | leukocyte cell-cell adhesion (GO:0007159) | 2.98746815 |
| 116 | cellular extravasation (GO:0045123) | 2.98264290 |
| 117 | lymph node development (GO:0048535) | 2.97517130 |
| 118 | translational termination (GO:0006415) | 2.97130509 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.96755786 |
| 120 | tolerance induction (GO:0002507) | 2.96257224 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94980528 |
| 122 | regulation of mast cell activation (GO:0033003) | 2.94880562 |
| 123 | response to protozoan (GO:0001562) | 2.93332140 |
| 124 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.92976180 |
| 125 | T cell proliferation (GO:0042098) | 2.92969422 |
| 126 | leukocyte homeostasis (GO:0001776) | 2.92264490 |
| 127 | defense response to protozoan (GO:0042832) | 2.89620254 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.88651269 |
| 129 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86529240 |
| 130 | positive regulation of isotype switching (GO:0045830) | 2.85913878 |
| 131 | B cell homeostasis (GO:0001782) | 2.84527934 |
| 132 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84449826 |
| 133 | neutrophil activation (GO:0042119) | 2.82790086 |
| 134 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82054249 |
| 135 | natural killer cell activation (GO:0030101) | 2.81791757 |
| 136 | alpha-beta T cell differentiation (GO:0046632) | 2.81294075 |
| 137 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.79221401 |
| 138 | response to type I interferon (GO:0034340) | 2.78945397 |
| 139 | positive regulation of DNA recombination (GO:0045911) | 2.76368544 |
| 140 | B cell activation (GO:0042113) | 2.75279576 |
| 141 | positive regulation of B cell activation (GO:0050871) | 2.74841430 |
| 142 | B cell differentiation (GO:0030183) | 2.74495810 |
| 143 | type I interferon signaling pathway (GO:0060337) | 2.74442035 |
| 144 | cellular response to type I interferon (GO:0071357) | 2.74442035 |
| 145 | T cell activation (GO:0042110) | 2.73613495 |
| 146 | positive regulation of tolerance induction (GO:0002645) | 2.73441190 |
| 147 | lymphocyte differentiation (GO:0030098) | 2.72411543 |
| 148 | leukocyte degranulation (GO:0043299) | 2.70708640 |
| 149 | dendritic cell chemotaxis (GO:0002407) | 2.70359869 |
| 150 | B cell proliferation (GO:0042100) | 2.67817435 |
| 151 | T cell lineage commitment (GO:0002360) | 2.66127206 |
| 152 | positive regulation of B cell proliferation (GO:0030890) | 2.65630342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.20241214 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.74305885 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59418182 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.13812098 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.85728587 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.53460362 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.46918521 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.44058024 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.21030526 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.09850269 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.06659920 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.97800730 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.94901812 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.92583945 |
| 15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87679787 |
| 16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.70345910 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.62640581 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51987956 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.49228746 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44855300 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.44549920 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38595428 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35385512 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.33210349 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.31705778 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24677354 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24499197 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18821081 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18721343 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18657296 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17950624 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13194970 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99345703 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97996989 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94906540 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91669766 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90133167 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84261076 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80587318 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76065265 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71958185 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.69613355 |
| 43 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68744138 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.66868227 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64490276 |
| 46 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.58022694 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54522128 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54422499 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47705250 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47006448 |
| 51 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.42428740 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42370588 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40059983 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.34456354 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32576716 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29512351 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29055580 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27240623 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26334104 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21867119 |
| 61 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21565651 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21510679 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20927799 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19726311 |
| 65 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19541286 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12444337 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12298245 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10119041 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09788981 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09373714 |
| 71 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09166885 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08466756 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06976934 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04416302 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03940710 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03762143 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02139802 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00565209 |
| 79 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.99752690 |
| 80 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98627890 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98125888 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97047170 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94682914 |
| 84 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.94676003 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94418574 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94134095 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89295474 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86568063 |
| 89 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86328689 |
| 90 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.85271054 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83138974 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82261047 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81009156 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80865691 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79792142 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79353137 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78787911 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78353169 |
| 99 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.77214687 |
| 100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76782430 |
| 101 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76151875 |
| 102 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75968622 |
| 103 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75916091 |
| 104 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.74415131 |
| 105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73099597 |
| 106 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.71748364 |
| 107 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71230843 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.70336535 |
| 109 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70083256 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.69443193 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69141164 |
| 112 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.68458744 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68400291 |
| 114 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.68290168 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68109509 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66463725 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65898630 |
| 118 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.65378992 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65003894 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64953201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.98426385 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.75201444 |
| 3 | MP0005671_abnormal_response_to | 3.54993700 |
| 4 | MP0001800_abnormal_humoral_immune | 3.20831832 |
| 5 | MP0000685_abnormal_immune_system | 3.08740312 |
| 6 | MP0001790_abnormal_immune_system | 2.84777679 |
| 7 | MP0005387_immune_system_phenotype | 2.84777679 |
| 8 | MP0009785_altered_susceptibility_to | 2.84219624 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.79559358 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.78989344 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.77456564 |
| 12 | MP0001819_abnormal_immune_cell | 2.75132861 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.73755148 |
| 14 | MP0002398_abnormal_bone_marrow | 2.66791339 |
| 15 | MP0002723_abnormal_immune_serum | 2.66329633 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.50213228 |
| 17 | MP0005025_abnormal_response_to | 2.46556871 |
| 18 | MP0003436_decreased_susceptibility_to | 2.39604950 |
| 19 | MP0000716_abnormal_immune_system | 2.33880013 |
| 20 | MP0003303_peritoneal_inflammation | 2.30345502 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.22341828 |
| 22 | MP0002419_abnormal_innate_immunity | 2.21513041 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.14227271 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.09601372 |
| 25 | MP0002722_abnormal_immune_system | 2.05987491 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.04876844 |
| 27 | MP0000703_abnormal_thymus_morphology | 2.03651604 |
| 28 | MP0000015_abnormal_ear_pigmentation | 2.03367178 |
| 29 | MP0003724_increased_susceptibility_to | 1.97744217 |
| 30 | MP0001873_stomach_inflammation | 1.96824299 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.95183222 |
| 32 | MP0005409_darkened_coat_color | 1.94376280 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.93390814 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.91426944 |
| 35 | MP0002429_abnormal_blood_cell | 1.89310718 |
| 36 | MP0002405_respiratory_system_inflammati | 1.87654223 |
| 37 | MP0004510_myositis | 1.85314562 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.83444257 |
| 39 | MP0002006_tumorigenesis | 1.75355814 |
| 40 | MP0003866_abnormal_defecation | 1.74062499 |
| 41 | MP0004381_abnormal_hair_follicle | 1.73152761 |
| 42 | MP0004883_abnormal_blood_vessel | 1.71566221 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.70925010 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.62467583 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.61527249 |
| 46 | MP0001853_heart_inflammation | 1.53718188 |
| 47 | MP0001188_hyperpigmentation | 1.51883470 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.51850198 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.51007449 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.49686296 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.44624652 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.44624652 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.43804986 |
| 54 | MP0005451_abnormal_body_composition | 1.37020923 |
| 55 | MP0002933_joint_inflammation | 1.24812079 |
| 56 | MP0003880_abnormal_central_pattern | 1.24505510 |
| 57 | MP0000858_altered_metastatic_potential | 1.22029447 |
| 58 | MP0009278_abnormal_bone_marrow | 1.21007534 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.20397913 |
| 60 | MP0004130_abnormal_muscle_cell | 1.19538840 |
| 61 | MP0000490_abnormal_crypts_of | 1.16483730 |
| 62 | MP0006082_CNS_inflammation | 1.14639268 |
| 63 | MP0005164_abnormal_response_to | 1.13068802 |
| 64 | MP0003690_abnormal_glial_cell | 1.10222089 |
| 65 | MP0002009_preneoplasia | 1.07854093 |
| 66 | MP0004947_skin_inflammation | 1.06561653 |
| 67 | MP0004859_abnormal_synaptic_plasticity | 1.04778268 |
| 68 | MP0003136_yellow_coat_color | 0.98185473 |
| 69 | MP0003787_abnormal_imprinting | 0.96926267 |
| 70 | MP0001663_abnormal_digestive_system | 0.92570699 |
| 71 | MP0008469_abnormal_protein_level | 0.91992804 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.91731472 |
| 73 | MP0009764_decreased_sensitivity_to | 0.91542918 |
| 74 | MP0002132_abnormal_respiratory_system | 0.91246264 |
| 75 | MP0005310_abnormal_salivary_gland | 0.90755963 |
| 76 | MP0001533_abnormal_skeleton_physiology | 0.90461832 |
| 77 | MP0008569_lethality_at_weaning | 0.90170087 |
| 78 | MP0002735_abnormal_chemical_nociception | 0.89106938 |
| 79 | MP0002822_catalepsy | 0.85429250 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85007734 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.84142482 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.83371087 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.82694340 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.81519795 |
| 85 | MP0000372_irregular_coat_pigmentation | 0.79786826 |
| 86 | MP0004484_altered_response_of | 0.79254241 |
| 87 | MP0009763_increased_sensitivity_to | 0.78314918 |
| 88 | MP0001968_abnormal_touch/_nociception | 0.75953932 |
| 89 | MP0009745_abnormal_behavioral_response | 0.74394519 |
| 90 | MP0003448_altered_tumor_morphology | 0.74334933 |
| 91 | MP0008874_decreased_physiological_sensi | 0.72763868 |
| 92 | MP0003075_altered_response_to | 0.72678445 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.68454566 |
| 94 | MP0005390_skeleton_phenotype | 0.65975077 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.65415066 |
| 96 | MP0000249_abnormal_blood_vessel | 0.63060506 |
| 97 | MP0003045_fibrosis | 0.62744698 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.61704667 |
| 99 | MP0000604_amyloidosis | 0.61436706 |
| 100 | MP0008260_abnormal_autophagy | 0.61349030 |
| 101 | MP0008058_abnormal_DNA_repair | 0.61037596 |
| 102 | MP0003635_abnormal_synaptic_transmissio | 0.60347349 |
| 103 | MP0002133_abnormal_respiratory_system | 0.54670319 |
| 104 | MP0005388_respiratory_system_phenotype | 0.54670319 |
| 105 | MP0008004_abnormal_stomach_pH | 0.54174242 |
| 106 | MP0005423_abnormal_somatic_nervous | 0.54064264 |
| 107 | MP0003828_pulmonary_edema | 0.53481854 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.53357692 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.52556240 |
| 110 | MP0002736_abnormal_nociception_after | 0.52423738 |
| 111 | MP0001851_eye_inflammation | 0.51418413 |
| 112 | MP0003091_abnormal_cell_migration | 0.50057904 |
| 113 | MP0001919_abnormal_reproductive_system | 0.49454847 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.49205651 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.49063710 |
| 116 | MP0003795_abnormal_bone_structure | 0.49057006 |
| 117 | MP0003252_abnormal_bile_duct | 0.47774200 |
| 118 | MP0002928_abnormal_bile_duct | 0.47135011 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.46304210 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.46027648 |
| 121 | MP0005166_decreased_susceptibility_to | 0.45996480 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.43069998 |
| 123 | MP0008995_early_reproductive_senescence | 0.42891729 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.40950669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.08233887 |
| 2 | Chronic otitis media (HP:0000389) | 4.66068421 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 4.44662783 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.40383103 |
| 5 | Meningitis (HP:0001287) | 4.38083027 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.26911906 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 4.26078011 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.26078011 |
| 9 | IgM deficiency (HP:0002850) | 4.24301430 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.17320116 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.13474635 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.07053104 |
| 13 | Stomatitis (HP:0010280) | 3.99953256 |
| 14 | T lymphocytopenia (HP:0005403) | 3.91350321 |
| 15 | Recurrent viral infections (HP:0004429) | 3.85875694 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.85340845 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.83908384 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.77615374 |
| 19 | Myositis (HP:0100614) | 3.73882573 |
| 20 | Cellulitis (HP:0100658) | 3.73622503 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.68406496 |
| 22 | Obstructive lung disease (HP:0006536) | 3.60323808 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.60323808 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.57167812 |
| 25 | Recurrent sinusitis (HP:0011108) | 3.37260386 |
| 26 | Abnormality of T cells (HP:0002843) | 3.37051501 |
| 27 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.33306209 |
| 28 | Hypochromic microcytic anemia (HP:0004840) | 3.33105396 |
| 29 | Recurrent skin infections (HP:0001581) | 3.24124240 |
| 30 | IgG deficiency (HP:0004315) | 3.16409163 |
| 31 | Urticaria (HP:0001025) | 3.15408682 |
| 32 | Gingival bleeding (HP:0000225) | 3.14988983 |
| 33 | Thrombocytosis (HP:0001894) | 3.09952132 |
| 34 | Nasal polyposis (HP:0100582) | 3.08617980 |
| 35 | Chronic sinusitis (HP:0011109) | 3.06869438 |
| 36 | Lymphopenia (HP:0001888) | 3.04014998 |
| 37 | Thyroiditis (HP:0100646) | 3.02104822 |
| 38 | Peritonitis (HP:0002586) | 3.01253564 |
| 39 | Abnormality of the fingertips (HP:0001211) | 2.97411792 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.96558327 |
| 41 | Hypochromic anemia (HP:0001931) | 2.96046368 |
| 42 | Verrucae (HP:0200043) | 2.95004016 |
| 43 | Papilloma (HP:0012740) | 2.95004016 |
| 44 | Encephalitis (HP:0002383) | 2.94356816 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.93550221 |
| 46 | Optic neuritis (HP:0100653) | 2.93550221 |
| 47 | Vasculitis (HP:0002633) | 2.93071807 |
| 48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.92888694 |
| 49 | Petechiae (HP:0000967) | 2.82047243 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.79704065 |
| 51 | Pulmonary embolism (HP:0002204) | 2.78860186 |
| 52 | Anorexia (HP:0002039) | 2.77463420 |
| 53 | Episodic fever (HP:0001954) | 2.74870069 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.69807631 |
| 55 | Epistaxis (HP:0000421) | 2.64720929 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.64523279 |
| 57 | Hemoptysis (HP:0002105) | 2.62645347 |
| 58 | Severe combined immunodeficiency (HP:0004430) | 2.59854348 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.59198120 |
| 60 | B lymphocytopenia (HP:0010976) | 2.58072476 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.58072476 |
| 62 | Increased IgM level (HP:0003496) | 2.55419267 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.50572652 |
| 64 | Colitis (HP:0002583) | 2.50008752 |
| 65 | Orchitis (HP:0100796) | 2.48819392 |
| 66 | Pustule (HP:0200039) | 2.47385959 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.46722280 |
| 68 | Slow saccadic eye movements (HP:0000514) | 2.39589723 |
| 69 | Abnormality of the pleura (HP:0002103) | 2.36328360 |
| 70 | Gangrene (HP:0100758) | 2.36063357 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.33786455 |
| 72 | Leukocytosis (HP:0001974) | 2.32260732 |
| 73 | Viral hepatitis (HP:0006562) | 2.31735904 |
| 74 | Eosinophilia (HP:0001880) | 2.30357817 |
| 75 | Combined immunodeficiency (HP:0005387) | 2.28567672 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.27373492 |
| 77 | Cheilitis (HP:0100825) | 2.26885210 |
| 78 | Chronic diarrhea (HP:0002028) | 2.26870869 |
| 79 | Keratoconjunctivitis sicca (HP:0001097) | 2.24334970 |
| 80 | Bronchitis (HP:0012387) | 2.23566823 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.23013522 |
| 82 | Lymphoma (HP:0002665) | 2.22306430 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.21984264 |
| 84 | Granulocytopenia (HP:0001913) | 2.19735509 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18380696 |
| 86 | Keratitis (HP:0000491) | 2.18285727 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 2.17775983 |
| 88 | Acute hepatic failure (HP:0006554) | 2.13553102 |
| 89 | Abnormal hair whorl (HP:0010721) | 2.13102662 |
| 90 | Increased IgE level (HP:0003212) | 2.12715357 |
| 91 | Abnormality of the endocardium (HP:0004306) | 2.12667294 |
| 92 | Abnormal platelet volume (HP:0011876) | 2.11460062 |
| 93 | Abnormality of macrophages (HP:0004311) | 2.10956311 |
| 94 | Stomach cancer (HP:0012126) | 2.09692280 |
| 95 | Arterial thrombosis (HP:0004420) | 2.09570195 |
| 96 | Hemiplegia (HP:0002301) | 2.09114102 |
| 97 | Osteomyelitis (HP:0002754) | 2.08874743 |
| 98 | Recurrent pneumonia (HP:0006532) | 2.07154432 |
| 99 | Chest pain (HP:0100749) | 2.06866887 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.05667171 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 2.05113474 |
| 102 | Reticulocytopenia (HP:0001896) | 2.04515223 |
| 103 | Glomerulopathy (HP:0100820) | 2.02438920 |
| 104 | Vertigo (HP:0002321) | 2.01667573 |
| 105 | Type I transferrin isoform profile (HP:0003642) | 2.01503676 |
| 106 | Sepsis (HP:0100806) | 2.00532230 |
| 107 | Aplastic anemia (HP:0001915) | 1.99400760 |
| 108 | Gastrointestinal infarctions (HP:0005244) | 1.99184171 |
| 109 | Papilledema (HP:0001085) | 1.97469749 |
| 110 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97108507 |
| 111 | Reduced antithrombin III activity (HP:0001976) | 1.96854805 |
| 112 | Skin ulcer (HP:0200042) | 1.96699117 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 1.96301787 |
| 114 | Abnormal platelet function (HP:0011869) | 1.96071380 |
| 115 | Impaired platelet aggregation (HP:0003540) | 1.96071380 |
| 116 | Microcytic anemia (HP:0001935) | 1.95854436 |
| 117 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95784308 |
| 118 | Skin rash (HP:0000988) | 1.94977404 |
| 119 | Gingivitis (HP:0000230) | 1.94864755 |
| 120 | Absent frontal sinuses (HP:0002688) | 1.91445672 |
| 121 | Clubbing of toes (HP:0100760) | 1.90932209 |
| 122 | Recurrent otitis media (HP:0000403) | 1.90743877 |
| 123 | Dry hair (HP:0011359) | 1.89508366 |
| 124 | Abnormal number of erythroid precursors (HP:0012131) | 1.88323896 |
| 125 | Poikiloderma (HP:0001029) | 1.88061804 |
| 126 | Joint swelling (HP:0001386) | 1.86788023 |
| 127 | Amyloidosis (HP:0011034) | 1.84713709 |
| 128 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81092325 |
| 129 | Acne (HP:0001061) | 1.80192255 |
| 130 | Polyneuropathy (HP:0001271) | 1.72641348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.01580591 |
| 2 | TXK | 4.07772639 |
| 3 | GRK6 | 2.68529361 |
| 4 | TEC | 2.64798152 |
| 5 | BTK | 2.39756280 |
| 6 | JAK3 | 2.38920827 |
| 7 | IRAK4 | 2.38065697 |
| 8 | FES | 2.27163540 |
| 9 | RIPK4 | 2.23669248 |
| 10 | MAP3K14 | 2.22859848 |
| 11 | NME2 | 2.22679331 |
| 12 | SYK | 2.11630853 |
| 13 | ITK | 2.07862704 |
| 14 | NLK | 2.05549696 |
| 15 | IKBKE | 2.03287845 |
| 16 | CLK1 | 1.95872353 |
| 17 | KIT | 1.87225995 |
| 18 | MAP3K12 | 1.85023501 |
| 19 | ZAP70 | 1.84202293 |
| 20 | TNIK | 1.81878534 |
| 21 | EPHB1 | 1.80290248 |
| 22 | TLK1 | 1.79090441 |
| 23 | MAP3K13 | 1.72622515 |
| 24 | MKNK2 | 1.71959857 |
| 25 | ERN1 | 1.66849463 |
| 26 | FGR | 1.65540873 |
| 27 | TYK2 | 1.62173837 |
| 28 | CASK | 1.61030850 |
| 29 | STK10 | 1.58239770 |
| 30 | BLK | 1.56018346 |
| 31 | LCK | 1.54252975 |
| 32 | HCK | 1.52508648 |
| 33 | SIK2 | 1.49842072 |
| 34 | IRAK3 | 1.32359304 |
| 35 | MAP3K3 | 1.30939402 |
| 36 | TNK2 | 1.30082150 |
| 37 | JAK1 | 1.29994294 |
| 38 | IKBKB | 1.27235436 |
| 39 | CSK | 1.24097073 |
| 40 | LYN | 1.18402240 |
| 41 | PRKD2 | 1.14968436 |
| 42 | FGFR3 | 1.14116310 |
| 43 | PIM1 | 1.11697380 |
| 44 | TBK1 | 1.10438347 |
| 45 | MAP3K11 | 1.08470821 |
| 46 | KSR2 | 1.05238806 |
| 47 | MAP3K1 | 1.04182570 |
| 48 | MUSK | 1.01980702 |
| 49 | CSF1R | 1.01917457 |
| 50 | PIK3CG | 0.99669690 |
| 51 | MAPK12 | 0.99223069 |
| 52 | TGFBR2 | 0.97990371 |
| 53 | PRKCQ | 0.95039997 |
| 54 | MAP2K7 | 0.93786564 |
| 55 | MAPK13 | 0.93077454 |
| 56 | MARK3 | 0.91647421 |
| 57 | PTK2B | 0.91493896 |
| 58 | SIK3 | 0.89977330 |
| 59 | MAP3K2 | 0.88896236 |
| 60 | FGFR4 | 0.88739022 |
| 61 | MAP3K10 | 0.85587355 |
| 62 | HIPK2 | 0.83108189 |
| 63 | PRPF4B | 0.81968634 |
| 64 | MAP3K6 | 0.81361204 |
| 65 | MKNK1 | 0.75176812 |
| 66 | CAMKK1 | 0.74074482 |
| 67 | IRAK2 | 0.73448074 |
| 68 | MAPK4 | 0.72568326 |
| 69 | BMPR2 | 0.71374389 |
| 70 | ADRBK2 | 0.70504550 |
| 71 | LRRK2 | 0.69546927 |
| 72 | MAP3K7 | 0.69295490 |
| 73 | JAK2 | 0.69042139 |
| 74 | PTK6 | 0.68295080 |
| 75 | MAP2K3 | 0.68184338 |
| 76 | EEF2K | 0.67672072 |
| 77 | WNK1 | 0.65896574 |
| 78 | CDK19 | 0.64082059 |
| 79 | DYRK1B | 0.63670880 |
| 80 | PRKCH | 0.63034769 |
| 81 | MST4 | 0.62430689 |
| 82 | EIF2AK3 | 0.61924878 |
| 83 | CAMK1 | 0.61176880 |
| 84 | YES1 | 0.60693082 |
| 85 | MAP2K4 | 0.58747095 |
| 86 | FRK | 0.57793597 |
| 87 | TAOK3 | 0.54851981 |
| 88 | IRAK1 | 0.53318509 |
| 89 | MAP3K5 | 0.52831555 |
| 90 | TRPM7 | 0.52024957 |
| 91 | PDPK1 | 0.49995185 |
| 92 | SGK494 | 0.49504526 |
| 93 | SGK223 | 0.49504526 |
| 94 | MAPK11 | 0.49112829 |
| 95 | MAP2K6 | 0.49092713 |
| 96 | RPS6KA6 | 0.48833804 |
| 97 | MARK2 | 0.46554088 |
| 98 | KSR1 | 0.45210433 |
| 99 | STK11 | 0.44050578 |
| 100 | CHUK | 0.43631666 |
| 101 | RET | 0.42405080 |
| 102 | NTRK3 | 0.42285278 |
| 103 | RPS6KL1 | 0.42170200 |
| 104 | RPS6KC1 | 0.42170200 |
| 105 | EPHA3 | 0.41702536 |
| 106 | GRK5 | 0.41510030 |
| 107 | MAPK7 | 0.40505265 |
| 108 | PDK1 | 0.40436559 |
| 109 | CDC42BPA | 0.39857633 |
| 110 | GRK7 | 0.39638453 |
| 111 | CAMKK2 | 0.38598328 |
| 112 | SGK2 | 0.37956722 |
| 113 | CAMK4 | 0.37090327 |
| 114 | SGK3 | 0.36505369 |
| 115 | RAF1 | 0.35879491 |
| 116 | RPS6KA4 | 0.34400353 |
| 117 | STK4 | 0.33299474 |
| 118 | CDK4 | 0.33217847 |
| 119 | FYN | 0.32704826 |
| 120 | MATK | 0.32595365 |
| 121 | TAOK1 | 0.32469460 |
| 122 | PRKCD | 0.32438075 |
| 123 | TAOK2 | 0.30394860 |
| 124 | CCNB1 | 0.30121928 |
| 125 | PRKCZ | 0.30002735 |
| 126 | CDK9 | 0.29033988 |
| 127 | PRKG2 | 0.28265327 |
| 128 | DAPK1 | 0.27601829 |
| 129 | STK38 | 0.27551001 |
| 130 | SRPK1 | 0.25648236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.18330509 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.52732314 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.44613257 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36183807 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.27952791 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20403711 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.15834548 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05536506 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02771652 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.00429917 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.00420521 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98552214 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87815999 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75544132 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.66680357 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65463989 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58544453 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45973354 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.45749393 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43938799 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39921723 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39416657 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35219705 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34748159 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34050290 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28465576 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.25872824 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24764494 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.23333276 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.23062750 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.21233703 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14039110 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12288793 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.09206470 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09094468 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.03227818 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02606613 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99075529 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 0.97302968 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 0.97054061 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 0.95466063 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93592996 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92143632 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91596262 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90073847 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89431895 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88074491 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87226570 |
| 49 | Base excision repair_Homo sapiens_hsa03410 | 0.84782999 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83412149 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83393762 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83026598 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.82874531 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82080356 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81994263 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81923317 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.80400418 |
| 58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80063410 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79227726 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78767711 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 0.77990996 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.76587540 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75741904 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75672036 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75559073 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.75434460 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74965922 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74532997 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74490933 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74367163 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.69811449 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69698257 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68965891 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68872115 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68792903 |
| 76 | DNA replication_Homo sapiens_hsa03030 | 0.68515412 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68347549 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.67952576 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67702238 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65964844 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65700602 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65178836 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.63986902 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63940533 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63852648 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62546135 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62506780 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61671997 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61619991 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60693580 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59859631 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59339397 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.59147643 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58002589 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57329497 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57017175 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56937813 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56459866 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56291901 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55806748 |
| 101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55545785 |
| 102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55343494 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54340083 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.53617045 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53442060 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52558519 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52557312 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52292163 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51847151 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51019620 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50961765 |
| 112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50513310 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49981846 |
| 114 | Spliceosome_Homo sapiens_hsa03040 | 0.47470098 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46013544 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.44711950 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44183623 |
| 118 | Long-term depression_Homo sapiens_hsa04730 | 0.43994541 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43594846 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42830123 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42590064 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41841392 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40868422 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40330868 |
| 125 | Taste transduction_Homo sapiens_hsa04742 | 0.40140026 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40057612 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.39905961 |
| 128 | Mismatch repair_Homo sapiens_hsa03430 | 0.39725447 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38472906 |

